XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Fcuk this shitt XORTEX

<< Previous

Bullboard Posts

Next >>

Comment by Richmondon Nov 10, 2021 6:05pm

108 Views

Post# 34112389

RE:RE:RE:Fcuk this shitt XORTEX

You like the fact, that the Rollback was done at 11.74 to get to $9.00 , for Nasdaq listing , but the damnnn thing tumbled to $3.87 . LOST TWO THIRD OF THE SHARE PRICE VALUE!!!!!. You must be an insider or kiss assseee who probably had insider info to sell at Rollback. Anyway, i don't give a rat's assseee, who ever you are, but the Executives of XORTEX has fooled the investors to further collect more PP funds at $ 4.00?... LOL. WAIT FOR TAX SELLING TOWARDS END OF2021 AT $2.00... SO GO AND FCUK YOURSELF!!!!!